Homepage
Author:
Creatv MicroTech, Inc.
Posted Date:
June 2, 2026
CREATV BIO AND NEOVIA ONCOLOGY ANNOUNCE STRATEGIC PARTNERSHIP TO STUDY MULTIPLE DRUG RESISTANCE (MDR) IN SOLID TUMORS
Creatv MicroTech, Inc.
June 2, 2026
CREATV BIO STUDIES PRESENTED AT AACR ANNUAL MEETING SHOWING IMPORTANCE OF MONITORING PD-L1, MITOTIC CTCs and CAMLs IN BLOOD
Creatv MicroTech, Inc.
May 22, 2026
Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development
Creatv MicroTech, Inc.
May 21, 2026
Creatv Announces Five Clinical Data Presentations at ASCO 2026
Creatv MicroTech, Inc.
May 5, 2026
Creatv Bio’s LifeTracDx® Blood Test Utilized as Exploratory Biomarker in CytoDyn’s Phase 2 Study in Patients with Relapsed/Refractory Metastatic Colorectal Cancer
Creatv MicroTech, Inc.
March 3, 2026
